本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

76.96
-0.9500-1.22%
成交量:70.70万
成交额:5,469.62万
市值:62.83亿
市盈率:-20.86
高:80.74
开:80.00
低:75.82
收:77.91
52周最高:103.00
52周最低:19.45
股本:8,164.24万
流通股本:5,462.66万
量比:1.14
换手率:1.29%
股息:- -
股息率:- -
每股收益(TTM):-3.6900
每股收益(LYR):-3.6900
净资产收益率:-25.78%
总资产收益率:-15.87%
市净率:3.98
市盈率(LYR):-20.86

数据加载中...

2026/03/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities